NeuroDerm's Series A Round

NeuroDerm raised a round of funding on August 07, 2009.

NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…

Articles about NeuroDerm's Series A Round: